STAT3 and prostate carcinoma: On the other hand, the enhancer of zeste homolog 2 (EZH2) component of the polycomb 2 complex determines K180 tri-methylation, which is essential for maintaining STAT3 phosphorylation and transcriptional activity in glioblastoma and prostate cancer cells [90].